Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-07-29 Purchase |
2025-07-30 5:12 pm |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Director |
27,500 | $0.91787 | $25,241 | 1,626,871 (Indirect Direct) |
View |
2025-07-29 Purchase |
2025-07-30 12:37 pm |
Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director |
5,000 | $0.9063 | $4,532 | 279,582 (Direct) |
View |
2025-07-29 Purchase |
2025-07-30 11:34 am |
Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President & CSO |
5,376 | $0.928 | $4,989 | 829,455 (Indirect Direct) |
View |
2025-07-29 Purchase |
2025-07-30 11:23 am |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
750 | $0.91 | $683 | 283,250 (Direct) |
View |
2025-07-29 Purchase |
2025-07-30 11:14 am |
Lexaria Bioscience Corp. | LEXX | CHRISTOPHER RICHARD Chief Executive Officer |
15,000 | $0.9094 | $13,641 | 665,000 (Direct) |
View |
2024-12-02 Purchase |
2024-12-03 2:03 pm |
Lexaria Bioscience Corp. | LEXX | CHRISTOPHER RICHARD Chief Executive Officer |
50,000 | $2.3678 | $118,392 | 250,000 (Direct) |
View |
2024-08-12 Purchase |
2024-08-13 10:55 am |
Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director |
1,600 | $3.13 | $5,008 | 65,000 (Direct) |
View |
2024-07-31 Sale |
2024-08-01 12:25 pm |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
2,567 | $4 | $10,268 | 210,536 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-05-15 Option Award |
2025-05-16 5:47 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | CHRISTOPHER RICHARD Chief Executive Officer |
150,000 | $0 | 600,000 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 5:39 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Director |
11,000 | $0 | 1,344,959 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 5:27 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
15,000 | $0 | 282,500 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 5:19 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President |
150,000 | $0 | 824,079 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 4:51 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | Shankman Michael Elliot Chief Financial Officer |
50,000 | $0 | 150,000 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 4:44 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | Bhullar Baljinder Director |
11,000 | $0 | 24,000 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 4:40 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director |
11,000 | $0 | 259,200 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 4:30 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director |
11,000 | $0 | 141,117 (Direct) |
View |
2025-05-15 Option Award |
2025-05-16 4:18 pm |
2025-05-15 2030-05-15 |
Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director |
11,000 | $0 | 261,391 (Direct) |
View |
Ownership |
2025-01-16 11:39 am |
N/A N/A |
Lexaria Bioscience Corp. | LEXX | Bhullar Baljinder Director |
0 | $0 | 13,000 (Direct) |
View |
2025-01-07 Option Award |
2025-01-10 11:52 am |
N/A N/A |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Director |
100,000 | $0 | 1,480,337 (Direct) |
View |
Ownership |
2024-10-02 3:45 pm |
2025-02-28 2029-10-01 |
Lexaria Bioscience Corp. | LEXX | Shankman Michael Elliot Chief Financial Officer |
0 | $0 | 50,000 (Direct) |
View |
Ownership |
2024-09-05 1:09 pm |
2025-02-28 2029-08-31 |
Lexaria Bioscience Corp. | LEXX | CHRISTOPHER RICHARD Chief Executive Officer |
0 | $0 | 200,000 (Direct) |
View |
2024-07-26 Option Award |
2024-07-30 11:39 am |
2024-07-26 2029-07-26 |
Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director |
12,000 | $0 | 98,117 (Direct) |
View |
2024-07-26 Option Award |
2024-07-30 11:32 am |
2024-07-26 2029-07-26 |
Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director |
12,000 | $0 | 61,900 (Direct) |
View |
2024-07-26 Option Award |
2024-07-30 11:25 am |
2024-07-26 2029-07-26 |
Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director |
12,000 | $0 | 196,200 (Direct) |
View |
2024-07-26 Option Award |
2024-07-30 11:12 am |
2024-07-26 2029-07-26 |
Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director |
12,000 | $0 | 198,391 (Direct) |
View |
2024-05-14 Exercise |
2024-05-15 5:37 pm |
2023-10-26 2028-10-26 |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
2,500 | $0 | 275,670 (Direct) |
View |
2024-05-14 Exercise |
2024-05-15 5:37 pm |
N/A N/A |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
2,500 | $1.15 | 275,670 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 5:24 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
10,000 | $0 | 213,036 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 5:16 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director |
5,000 | $0 | 34,900 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 5:11 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director |
5,000 | $0 | 144,200 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 5:03 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director |
5,000 | $0 | 146,391 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 4:52 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director |
5,000 | $0 | 66,117 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 4:44 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer |
49,500 | $0 | 1,106,794 (Direct) |
View |
2024-04-26 Option Award |
2024-05-10 4:34 pm |
2024-04-26 2029-04-26 |
Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President |
49,500 | $0 | 606,583 (Direct) |
View |
Ownership |
2024-03-15 4:22 pm |
2024-03-15 2029-03-15 |
Lexaria Bioscience Corp. | LEXX | Cabatuan Nelson Chief Financial Officer |
0 | $0 | 200,000 (Direct) |
View |
2023-10-26 Option Award |
2023-11-01 1:45 pm |
2023-10-26 2028-10-26 |
Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary |
12,500 | $0 | 150,469 (Direct) |
View |
2023-10-26 Option Award |
2023-10-30 12:47 pm |
2023-10-26 2028-10-26 |
Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President |
30,000 | $0 | 432,415 (Direct) |
View |
2023-10-26 Option Award |
2023-10-30 12:30 pm |
2023-10-26 2028-10-26 |
Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer |
30,000 | $0 | 926,293 (Direct) |
View |
2023-07-25 Option Award |
2023-07-25 2:35 pm |
2023-07-25 2028-07-25 |
Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director |
5,000 | $0 | 104,200 (Direct) |
View |
2023-07-25 Option Award |
2023-07-25 2:09 pm |
2023-07-25 2028-07-25 |
Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director |
5,000 | $0 | 106,391 (Direct) |
View |
2023-07-25 Option Award |
2023-07-25 1:56 pm |
2023-07-25 2028-07-25 |
Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director |
5,000 | $0 | 46,117 (Direct) |
View |